References
- Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40.
- Drorge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95.
- Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release 2006;113:189–207.
- Suzen S. Antioxidant activities of synthetic indole derivatives and possible activity mechanisms. Topic Heterocyclic Chem 2007;11:145–178.
- Gürsoy A, Karali N. Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinones. Eur J Med Chem 2003;38:633–643.
- Debra CQ, Kathy AK, Kern ER. In vitro and in vivo evaluation of isatin-β-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res 2006;71:24–30.
- Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm Acta Helv 1999;74:11–17.
- Karali N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Ozbey S et al. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 2007;15:5888–5904.
- Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. Farmaco 1999;54:624–628.
- Sridhar SK, Ramesh A. Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives. Biol Pharm Bull 2001;24:1149–1152.
- Verma M, Pandeya SN, Singh KN, Stables JP. Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm 2004;54:49–56.
- Kara LV, Julie ML, Marie R, Stephen GP, John BB. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins. J Med Chem 2007;50:5109–5117
- Prasad RK, Narsinghani T, Sharma R. QSAR analysis of novel N-alkyl substituted isatins derivatives as anticancer agents. J Chem Pharma Res 2009;1:199–204.
- Raja SV, Changkun H, Hoyun L. Hybrid pharmacophore design and synthesis of isatin–benzothiazole analogs for their anti-breast cancer activity. Bioorg Med Chem 2009;17:7585–7589.
- Bahl AA. Textbook of Organic Chemistry, 5th edn. New Delhi: S. Chand and Company Ltd, 2004, pp. 364–370.
- Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757–766.
- Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107–1112.
- Blios MS. Antioxidant determination by the use of stable free radical. Nature 1958;26:1199–1200.
- Leong CO, Gaskell M, Martin EA, Heydon RT, Farmer PB, Bibby MC et al. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Br J Cancer 2003;88:470–477.
- Osbild S, Brault L, Battaglia E, Bagrel D. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells. Anticancer Res 2006;26:3595–3600.
- Cane A, Tournaire MC, Barritault D, Crumeyrolle-Arias M. The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun 2000;276:379–384.
- Lee D, Long SA, Murray JH, Adams JL, Nuttall ME, Nadeau DP et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem 2001;44:2015–2026.
- Hari HP, Umashankar D, Wilson JQ, Masami K, Hiroshi S, Jonathan RD. Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Eur J Med Chem 2008;43:1–7.
- Ranjit K, Rao GK, Pai PNS. Synthesis and biological evaluation of N1-[(3z)-5-substituted-2-Oxo-1, 2-dihydro-3H-indol-3-ylidene]-5H-dibenzo [b,f] azepine-5-carbohydrazides. Int J Biol Chem 2010;4:19–26.
- Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007;33:407–418.